Topical cyclosporine 2% for herpetic interstitial keratitis
Not Applicable
- Conditions
- Herpetic interstitial keratitis.Herpesviral keratitis and keratoconjunctivitis
- Registration Number
- IRCT2015052112724N2
- Lead Sponsor
- Vice chancellor for research, Isfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 48
Inclusion Criteria
Diagnosis of herpetic interstitial keratitis, No history of treatment with any form of immunosuppressant drugs one month before intervention, No history of diabetes mellitus, No history of co-existing viral disease.
Exclusion criteria: Any side effect attributable to study, patients who have not used drugs regularly, patients who have not come for follow up visits.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cornea haziness. Timepoint: Before and 1 month after treatment. Method of measurement: Pentacam optical densitometry.
- Secondary Outcome Measures
Name Time Method Visual acuity. Timepoint: Before and 1 month after treatment. Method of measurement: Snellen chart.